All bills
HB 433 Acts of Assembly Chapter text (CHAP0392)

Newborn screening; evaluation of disorders for inclusion, process for considering other disorders.

Official Bill Page

Loading official bill page…

Legislative Timeline

48 actions
  1. Apr 8, 2026 executive
    Acts of Assembly Chapter text (CHAP0392)
  2. Apr 8, 2026 executive
    Approved by Governor-Chapter 392 (effective 7/1/2026)
  3. Mar 31, 2026 executive
    Governor's Action Deadline 11:59 p.m., April 13, 2026
  4. Mar 31, 2026 lower
    Enrolled Bill communicated to Governor on March 31, 2026
  5. Mar 31, 2026 lower
    Signed by Speaker
  6. Mar 31, 2026 lower
    Fiscal Impact Statement from Department of Planning and Budget (HB433)
  7. Mar 30, 2026 upper
    Signed by President
  8. Mar 30, 2026 lower
    Bill text as passed House and Senate (HB433ER)
  9. Mar 30, 2026 lower
    Enrolled
  10. Mar 19, 2026 lower
    Fiscal Impact Statement from Department of Planning and Budget (HB433)
  11. Mar 14, 2026 lower
    Conference report agreed to by House (94-Y 0-N 0-A)
  12. Mar 13, 2026 upper
    Conference report agreed to by Senate (39-Y 0-N 0-A)
  13. Mar 13, 2026 legislature
    Conference Report released
  14. Mar 12, 2026 lower
    House Conferees: LeVere Bolling, Downey, McLaughlin
  15. Mar 12, 2026 lower
    Conferees appointed by House
  16. Mar 12, 2026 upper
    Senate Conferees: Aird, Boysko, Peake
  17. Mar 12, 2026 upper
    Conferees appointed by Senate
  18. Mar 11, 2026 lower
    House acceded to request
  19. Mar 10, 2026 upper
    Senate requested conference committee
  20. Mar 10, 2026 upper
    Senate insisted on substitute (40-Y 0-N 0-A)
  21. Mar 6, 2026 lower
    Senate substitute rejected by House (3-Y 94-N 0-A)
  22. Mar 4, 2026 lower
    Fiscal Impact Statement from Department of Planning and Budget (HB433)
  23. Mar 4, 2026 upper
    Passed Senate with substitute Block Vote (40-Y 0-N 0-A)
  24. Mar 4, 2026 upper
    Engrossed by Senate - committee substitute
  25. Mar 4, 2026 upper
    Finance and Appropriations Substitute agreed to
  26. Mar 4, 2026 upper
    Read third time
  27. Mar 4, 2026 upper
    Committee substitute printed 26109168D-S1
  28. Mar 3, 2026 upper
    Passed by for the day (Voice Vote)
  29. Mar 3, 2026 upper
    Constitutional reading dispensed (on 2nd reading) (40-Y 0-N 0-A)
  30. Mar 3, 2026 upper
    Rules suspended
  31. Mar 3, 2026 upper
    Reported from Finance and Appropriations with substitute (14-Y 0-N)
  32. Feb 19, 2026 upper
    Reported from Education and Health and rereferred to Finance and Appropriations (15-Y 0-N)
  33. Feb 13, 2026 lower
    Fiscal Impact Statement from Department of Planning and Budget (HB433)
  34. Feb 5, 2026 lower
    Fiscal Impact Statement from Department of Planning and Budget (HB433)
  35. Feb 3, 2026 upper
    Referred to Committee on Education and Health
  36. Feb 3, 2026 upper
    Constitutional reading dispensed (on 1st reading)
  37. Feb 2, 2026 lower
    Read third time and passed House (99-Y 0-N 0-A)
  38. Jan 30, 2026 lower
    Engrossed by House - committee substitute
  39. Jan 30, 2026 lower
    committee substitute agreed to
  40. Jan 30, 2026 lower
    Read second time
  41. Jan 29, 2026 lower
    Read first time
  42. Jan 27, 2026 lower
    Committee substitute printed 26106107D-H1
  43. Jan 27, 2026 lower
    Reported from Rules with substitute (18-Y 0-N)
  44. Jan 23, 2026 lower
    Subcommittee recommends reporting with substitute (5-Y 0-N)
  45. Jan 23, 2026 lower
    House subcommittee offered
  46. Jan 22, 2026 lower
    Assigned HRUL sub: Studies Subcommittee
  47. Jan 12, 2026 lower
    Referred to Committee on Rules
  48. Jan 12, 2026 lower
    Prefiled and ordered printed; Offered 01-14-2026 26104699D
About this civic dataset

About this legislation view

Track federal and state bills and legislation — browse by chamber, status, and day, with summaries and sponsor details, updated daily on Civic Stream.

Use the scope, chamber, status, and search controls to move from the national legislation picture down to an exact state or legislative stage.